Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment for postoperative recurrent EGFR -mutated lung adenocarcinoma: a multi-institutional retrospective study - Miyata, Ryo; Hamaji, Masatsugu; Kawaguchi, Atsushi; Shimazu, Yumeta; Ikeda, Masaki; Ishikawa, Masashi; Kayawake, Hidenao; Menju, Toshi; Kobayashi, Masashi; Okumura, Norihito; Sakaguchi, Yasuto; Sonobe, Makoto; et al. (European journal of cardio-thoracic surgery, 2022)